Old Web
English
Sign In
Acemap
>
Paper
>
OS01.5 Development of TERT-targeting therapy using eribulin mesylate in mouse glioblastoma model
OS01.5 Development of TERT-targeting therapy using eribulin mesylate in mouse glioblastoma model
2017
Miwako Takahashi
Shunichiro Miki
Kouhei Fukuoka
Mami Yasukawa
Mitsuhiro Hayashi
Akinobu Hamada
Akitake Mukasa
Ryo Nishikawa
Kenji Tamura
Yoshitaka Narita
Kenkichi Masutomi
Kohichi Ichimura
Keywords:
Pathology
Glioblastoma
Mouse Glioblastoma
Stem cell
Phenotype
Medicine
Cytotoxicity
Eribulin Mesylate
Cancer research
Telomerase
targeting therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]